Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

News

Cefdinir for Oral Suspension Recalled

Lupin Pharmaceuticals Inc. is recalling a single lot of 60-mL bottles of cefdinir for oral suspension, 250 mg/5 mL (NDC 68180-723-20), after a customer found a piece of metal in the powder prior to reconstitution. The recall appeared in the June 5, 2019, US Food and Drug Administration (FDA) Enforcement Report. 

The recall affects 18,408 bottles containing cefdinir powder for oral suspension from lot F802335 (Exp. 11/20). The bottles were distributed throughout the United States. 

Lupin Pharmaceuticals voluntarily initiated the recall May 23, 2019. On May 30, 2019, the FDA designated the recall Class II, communicating use of the drug may cause temporary or medically reversible adverse health consequences or a remote possibility of serious harm.

Cefdinir is a prescription antibiotic used to treat a variety of bacterial infections. 

Jolynn Tumolo

Advertisement

Advertisement